ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 156 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $350,000 | -3.8% | 12,493 | -10.9% | 0.01% | +14.3% |
| Q4 2020 | $364,000 | -25.3% | 14,019 | +7.1% | 0.01% | -46.2% |
| Q3 2020 | $487,000 | +35.7% | 13,091 | +87.0% | 0.01% | +30.0% |
| Q2 2020 | $359,000 | +32.5% | 7,000 | -56.2% | 0.01% | -16.7% |
| Q1 2016 | $271,000 | -23.9% | 16,000 | 0.0% | 0.01% | -52.0% |
| Q4 2015 | $356,000 | +50.8% | 16,000 | +60.0% | 0.02% | +150.0% |
| Q3 2015 | $236,000 | -93.2% | 10,000 | -76.4% | 0.01% | -92.7% |
| Q2 2015 | $3,467,000 | -6.4% | 42,400 | +6.0% | 0.14% | -16.5% |
| Q1 2015 | $3,704,000 | -8.4% | 40,000 | -60.0% | 0.16% | +17.1% |
| Q4 2014 | $4,044,000 | +451.0% | 100,000 | +233.3% | 0.14% | +677.8% |
| Q3 2014 | $734,000 | +54.5% | 30,000 | 0.0% | 0.02% | +80.0% |
| Q2 2014 | $475,000 | +4.6% | 30,000 | 0.0% | 0.01% | +11.1% |
| Q1 2014 | $454,000 | -44.9% | 30,000 | -50.0% | 0.01% | -50.0% |
| Q4 2013 | $824,000 | -78.2% | 60,000 | -70.0% | 0.02% | -56.1% |
| Q3 2013 | $3,772,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |